ArticleClinical journal of the American Society of Nephrology : CJASN2026
Long-Term Exposure to Fine Particulate Matter and Kidney Function among Patients with Polycystic Kidney Disease.
Article in Clinical journal of the American Society of Nephrology : CJASN, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Nature and Nurture? The Case of Polycystic Kidney Disease.Clinical journal of the American Society of Nephrology : CJASN · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
key pointsLong-term exposure to fine particulate matter was associated with faster decline in kidney function among patients with polycystic kidney disease. Associations were stronger in younger patients and those with preserved kidney function at baseline. The association was weaker among patients prescribed tolvaptan.
backgroundPolycystic kidney disease (PKD) is the fourth leading cause of ESKD. Although the condition is primarily genetic, environmental exposures such as air pollution may influence disease progression.
methodsWe investigated whether long-term exposure to fine particulate matter (PM 2 . 5 ) is associated with kidney function decline among individuals with PKD and whether this association differs by age, sex, initial kidney function, and tolvaptan use. Using the Korea National Health Information Database, we identified 18,898 adults with PKD who underwent at least two health screenings between 2016 and 2023. Annual mean PM 2 . 5 exposure was estimated with a high-resolution (1 km 2 ) machine learning-based model. Linear mixed-effects models were applied to assess the association between PM 2 . 5 exposure and changes in eGFR, adjusting for demographic, socioeconomic, and lifestyle covariates.
resultsEach 1 µ g/m 3 higher lag 0-1 year PM 2 . 5 was associated with a -0.09 ml/min per 1.73 m 2 change in eGFR (95% confidence interval [CI], -0.16 to -0.01). More evident associations were observed among younger adults (-0.26; 95% CI, -0.42 to -0.09), individuals with preserved baseline kidney function (-0.14; 95% CI, -0.21 to -0.07), male (-0.10; 95% CI, -0.21 to 0), and individuals who were not prescribed tolvaptan (-0.12; 95% CI, -0.20 to -0.04).
conclusionsChronic exposure to PM 2 . 5 appears to be an environmental modifier of kidney function decline in PKD, particularly among younger individuals and those with preserved kidney function. Environmental risk reduction strategies, together with pharmacologic therapy, may help delay the onset of ESKD in this vulnerable population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.